DealCloud and CRM · Private equity AI
AI Company Research and Screening for Private Equity
Private equity screening needs a clear distinction between a thesis match, a missing fact and an unsupported inference. We build sourced company briefs around your investment criteria and unresolved questions, with analyst review and traceability rather than unsupported investment conclusions.
A consistent research brief that supports screening and discussion without presenting unsupported conclusions as verified diligence.
Discuss ai company research and screening. Request an introductory conversation with our team.
- 01
Briefs contain polished conclusions without a clear evidence trail.
- 02
Source-linked company profile
- 03
Owner review
- 04
Reviewers can inspect changes and refresh the approved brief.
The private equity investment case
What should an AI-generated company research brief contain?
Deal teams need a clear account of what is known, what is uncertain, and what deserves investigation. AI-assisted research can organize available information around the investment thesis while preserving source dates, conflicting evidence, and open questions.
A useful brief includes the company's activities, relevant markets, ownership evidence, available financial information, and fit against the firm's criteria. Each material statement should be traceable to an approved source. Analytical interpretation, outdated information, conflicting accounts, and missing evidence should be labeled rather than blended into a confident narrative.
- A focused first project
- Approved-source review, entity verification, structured research templates, evidence references, criteria-based screening, and analyst review. This does not replace legal, financial, or commercial diligence.
- Who we work with
- Deal professional or research lead responsible for validating material claims and deciding next steps.
The problem
Where the investment thesis meets operational friction
Research summaries omit the original source or publication date.
Conflicting company identities and ownership accounts go unnoticed.
Analysts rebuild the same basic company profile for different meetings.
What we build with your team
AI Company Research and Screening
Source-linked company profile
For example, assemble a company profile from approved filings and business information, attaching source dates to ownership, product, and market statements while marking unsupported details unknown.
Thesis screening memo
For example, compare available company evidence with the firm's investment criteria, explain apparent matches, and separate missing financial data from negative findings that actually contradict requirements.
Research change review
For example, compare updated approved sources with an earlier brief, highlight changed statements, and send material ownership or strategy differences to an analyst for explicit review.
Example workflow
Before and after
Today
Briefs contain polished conclusions without a clear evidence trail.
Analysts confuse missing information with a failed criterion.
Old summaries circulate after important source information changes.
With Agentic Factory
Material claims link to identifiable sources and dates.
Screening distinguishes contradiction, uncertainty, and supported fit.
Reviewers can inspect changes and refresh the approved brief.
Systems and access
- Approved filings, news, company publications, and licensed information sources.
- Research template and evidence register with dates and entity identifiers.
- Controlled research workspace and optional CRM handoff subject to access.
Human approval
- Research owner validates material claims, entity identity, and screening conclusions.
- Authorized users approve publication or storage in shared deal records.
Metrics to track
- Material claims with traceable supporting sources.
- Reviewer corrections, unresolved contradictions, and missing required fields.
- Preparation time and brief freshness, distinct from any financial savings.
Our process
From opportunity to measured result
Assess research decisions, source permissions, and the firm's screening criteria. Prioritize a brief structure that captures relevant facts, uncertainty, and open questions. Build source collection, entity checks, citations, and clear labels for inference. Integrate approved outputs with the research workspace or CRM where feasible. Launch with analyst review of material statements. Measure traceability, correction rates, completeness, and preparation time. Refresh briefs according to agreed triggers, retaining source dates and documenting how conflicting or unavailable evidence affects each screening conclusion presented.
- 01
Assess
- 02
Prioritize
- 03
Build
- 04
Integrate
- 05
Launch
- 06
Measure
Start with your workflow, system constraints and value creation priorities.
Questions
AI Company Research and Screening for Private Equity: FAQs
Can AI research replace analyst review?+
It can assist collection and organization, but an accountable reviewer should validate material statements and interpretations. Sources can be incomplete, outdated, or contradictory. Investment relevance also depends on context that a standardized research workflow may not capture.
How are sources shown?+
Attach identifiable references and dates to material claims, subject to source permissions and retention rules. A general bibliography is less useful than claim-level traceability. Where a source supports only part of a statement, narrow the statement or label the interpretation.
What happens when sources disagree?+
Preserve the disagreement and identify the sources, dates, and affected conclusion. The reviewer may prefer a more authoritative or recent account, but that choice should be explained. Do not silently combine incompatible facts into a single confident answer.
Can the brief assess investment fit?+
It can compare available evidence with the firm's stated criteria, including industry, size, ownership, and geography. That is preliminary screening, not an investment recommendation. Missing financial data or uncertain ownership should remain visible limitations on the conclusion.
How current will the research be?+
Currency depends on available sources and the agreed refresh process. Show publication and review dates, and define triggers for updating material information. A recently generated summary can still contain old underlying evidence, so generation time alone is not sufficient.
Related private equity AI services
Explore all private equity servicesDealCloud AI Automation for Private Equity
DealCloud and CRMDealCloud Integration Services for Private Equity
DealCloud and CRMDealCloud Data Migration for Private Equity
Private equityAI Opportunity Assessment for Private Equity-Backed Companies
Put a real workflow on the table.
Discuss ai company research and screening. We’ll discuss fit, priorities and a sensible first scope.